SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Biomedquantum
Biomedquantum Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Biomedquantum Spółka z Ograniczoną Odpowiedzialnością
Biomedquantum Spółka z Ograniczoną Odpowiedzialnością (KRS 0000715295, NIP 5423294690) is a Polish company, headquartered in Białystok, Podlaskie voivodeship. BIOMEDQUANTUM operates in: Development of building projects (PKD 41.10.Z). Industry: Building construction. The company has been listed in the National Court Register since January 23, 2018.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Founded
January 23, 2018
8 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
BIAŁYSTOK
PODLASKIE
Primary PKD
41.10.Z
Development of building projects
Share capital
5.0 K PLN
Shareholders
3
shareholders
Board
1 person
Filed years
N/A
Registry entries
25
latest: March 21, 2025
No KPI data - financial statements and valuation are unavailable for this company.
Rate business credibility - Biomedquantum.
No ratings

News
Wrocław-based Archicom S.A. (KRS 0000555355) closed 2025 with revenue of PLN 961.7 m (+30% YoY), standalone net profit of PLN 229.9 m and 2,847 apartments sold (+30% YoY versus market +9.3%). The board recommends a PLN 1.80 per share dividend (PLN 105.3 m); the final decision rests with the AGM (scheduled for July 2026). The 2026 target: 3,200-3,500 units plus a debut in the Tricity. The first full year under Echo Investment control (74.04%) after the 2023 integration.

News
Cieszyn-based Atal S.A. (KRS 0000262397) closed 2025 with revenue of PLN 1.267 bn, net profit of PLN 223.3 m and a 17.6% net margin. The board recommends a PLN 4.50 per share dividend (88% of profit, PLN 194.67 m in total, ~8.6% yield) - lower than the PLN 6.00 paid out of 2024 but still among the highest in the Polish residential-developer sector. Q1 2026 saw handovers double (500 vs 218 YoY); 2026 targets are 2,500-3,000 sold and 3,000-4,000 handed over. Juroszek Holding control: 76.30% of capital.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
BIOMEDQUANTUM's board has 1 member.
20 historical registry entries for Biomedquantum
Filing documents submitted (3 documents)
Filing documents submitted (3 documents)
Filing documents submitted (6 documents)
Filing documents submitted (3 documents)
Filing documents submitted (3 documents)
Latest reporting year
2024
Available years
7
Filing entries
0
Competing companies or those operating in the same market segment as Biomedquantum (in Białystok, industry: Building construction).
GDAŃSK· Building construction
Revenue 2024: 5.4 M PLN
WARSZAWA· Building construction
Revenue 2024: 2.1 M PLN
PRUSZKÓW· Building construction
Revenue 2024: 4.8 K PLN
BIAŁYSTOK· Building construction
Revenue 2022: 0 PLN
RZESZÓW· Building construction
Revenue 2024: 0 PLN
POLKOWICE· Building construction